Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

Investigation of 5'-Norcarbocyclic Nucleoside Analogues as Antiprotozoal and Antibacterial Agents.

Khandazhinskaya AL, Matyugina ES, Solyev PN, Wilkinson M, Buckheit KW, Buckheit RW Jr, Chernousova LN, Smirnova TG, Andreevskaya SN, Alzahrani KJ, Natto MJ, Kochetkov SN, de Koning HP, Seley-Radtke KL.

Molecules. 2019 Sep 21;24(19). pii: E3433. doi: 10.3390/molecules24193433.

2.

New assay to diagnose and differentiate between Mycobacterium tuberculosis complex and nontuberculous mycobacteria.

Ustinova VV, Smirnova TG, Sochivko DG, Varlamov DA, Larionova EE, Andreevskaya SN, Andrievskaya IY, Kiseleva EA, Chernousova LN, Ergeshov A.

Tuberculosis (Edinb). 2019 Jan;114:17-23. doi: 10.1016/j.tube.2018.10.004. Epub 2018 Oct 9.

PMID:
30711153
3.

Novel 5'-Norcarbocyclic Pyrimidine Derivatives as Antibacterial Agents.

Khandazhinskaya AL, Alexandrova LA, Matyugina ES, Solyev PN, Efremenkova OV, Buckheit KW, Wilkinson M, Buckheit RW Jr, Chernousova LN, Smirnova TG, Andreevskaya SN, Leonova OG, Popenko VI, Kochetkov SN, Seley-Radtke KL.

Molecules. 2018 Nov 23;23(12). pii: E3069. doi: 10.3390/molecules23123069.

4.

[ADP-Induced Recalcified Blood Clotting Time as a Marker of Rethrombosis Risk and Effectiveness of Antiplatelet Therapy in Acute Coronary Syndrome].

Malinova LI, Furman NV, Dolotovskaya PV, Chernousova LA, Denisova TP.

Kardiologiia. 2018 Jun;58(6):5-12. Russian.

PMID:
30362431
5.

Draft Genome Sequence of a Mycobacterium heckeshornense Clinical Isolate.

Ustinova V, Smirnova T, Varlamov D, Monakhova Y, Larionova E, Andreevskaya S, Andrievskaya I, Chernousova L, Ergeshov A.

Genome Announc. 2018 Mar 29;6(13). pii: e00178-18. doi: 10.1128/genomeA.00178-18.

6.

[The Spectrum of Mutations in Genes Associated with Resistance to Rifampicin, Isoniazid, and Fluoroquinolones in the Clinical Strains of M. tuberculosis Reflects the Transmissibility of Mutant Clones].

Ergeshov A, Andreevskaya SN, Larionova EE, Smirnova TG, Chernousova LN.

Mol Biol (Mosk). 2017 Jul-Aug;51(4):595-602. doi: 10.7868/S0026898417030041. Russian.

7.

Severe Tuberculosis in Humans Correlates Best with Neutrophil Abundance and Lymphocyte Deficiency and Does Not Correlate with Antigen-Specific CD4 T-Cell Response.

Panteleev AV, Nikitina IY, Burmistrova IA, Kosmiadi GA, Radaeva TV, Amansahedov RB, Sadikov PV, Serdyuk YV, Larionova EE, Bagdasarian TR, Chernousova LN, Ganusov VV, Lyadova IV.

Front Immunol. 2017 Aug 21;8:963. doi: 10.3389/fimmu.2017.00963. eCollection 2017.

8.

Dual-targeted anti-TB/anti-HIV heterodimers.

Alexandrova L, Zicari S, Matyugina E, Khandazhinskaya A, Smirnova T, Andreevskaya S, Chernousova L, Vanpouille C, Kochetkov S, Margolis L.

Antiviral Res. 2017 Sep;145:175-183. doi: 10.1016/j.antiviral.2017.07.011. Epub 2017 Jul 22.

9.

Antigen-Specific IFN-γ Responses Correlate with the Activity of M. tuberculosis Infection but Are Not Associated with the Severity of Tuberculosis Disease.

Nikitina IY, Panteleev AV, Sosunova EV, Karpina NL, Bagdasarian TR, Burmistrova IA, Andreevskaya SN, Chernousova LN, Vasilyeva IA, Lyadova IV.

J Immunol Res. 2016;2016:7249369. doi: 10.1155/2016/7249369. Epub 2016 Nov 30.

10.

First Draft Genome Sequence of a Mycobacterium gordonae Clinical Isolate.

Ustinova V, Smirnova T, Blagodatskikh K, Varlamov D, Sochivko D, Larionova E, Andreevskaya S, Andrievskaya I, Chernousova L.

Genome Announc. 2016 Jun 30;4(3). pii: e00638-16. doi: 10.1128/genomeA.00638-16.

11.

Antibacterial Effects of Liposomes Containing Phospholipid Cardiolipin and Fluoroquinolone Levofloxacin on Mycobacterium tuberculosis with Extensive Drug Resistance.

Gaidukevich SK, Mikulovich YL, Smirnova TG, Andreevskaya SN, Sorokoumova GM, Chernousova LN, Selishcheva AA, Shvets VI.

Bull Exp Biol Med. 2016 Mar;160(5):675-8. doi: 10.1007/s10517-016-3247-z. Epub 2016 Mar 29.

PMID:
27021087
12.

Mycobacterium tuberculosis Type II Toxin-Antitoxin Systems: Genetic Polymorphisms and Functional Properties and the Possibility of Their Use for Genotyping.

Zaychikova MV, Zakharevich NV, Sagaidak MO, Bogolubova NA, Smirnova TG, Andreevskaya SN, Larionova EE, Alekseeva MG, Chernousova LN, Danilenko VN.

PLoS One. 2015 Dec 14;10(12):e0143682. doi: 10.1371/journal.pone.0143682. eCollection 2015.

13.

Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance.

Cegielski JP, Kurbatova E, van der Walt M, Brand J, Ershova J, Tupasi T, Caoili JC, Dalton T, Contreras C, Yagui M, Bayona J, Kvasnovsky C, Leimane V, Kuksa L, Chen MP, Via LE, Hwang SH, Wolfgang M, Volchenkov GV, Somova T, Smith SE, Akksilp S, Wattanaamornkiet W, Kim HJ, Kim CK, Kazennyy BY, Khorosheva T, Kliiman K, Viiklepp P, Jou R, Huang AS, Vasilyeva IA, Demikhova OV; Global PETTS Investigators, Lancaster J, Odendaal R, Diem L, Perez TC, Gler T, Tan K, Bonilla C, Jave O, Asencios L, Yale G, Suarez C, Walker AT, Norvaisha I, Skenders G, Sture I, Riekstina V, Cirule A, Sigman E, Cho SN, Cai Y, Eum S, Lee J, Park S, Jeon D, Shamputa IC, Metchock B, Kuznetsova T, Akksilp R, Sitti W, Inyapong J, Kiryanova EV, Degtyareva I, Nemtsova ES, Levina K, Danilovits M, Kummik T, Lei YC, Huang WL, Erokhin VV, Chernousova LN, Andreevskaya SN, Larionova EE, Smirnova TG.

Clin Infect Dis. 2016 Feb 15;62(4):418-430. doi: 10.1093/cid/civ910. Epub 2015 Oct 27.

14.

Draft Genome Sequences of Two Pyrazinamide-Resistant Clinical Isolates, Mycobacterium tuberculosis 13-4152 and 13-2459.

Maslov DA, Shur KV, Bekker OB, Zakharevich NV, Zaichikova MV, Klimina KM, Smirnova TG, Zhang Y, Chernousova LN, Danilenko VN.

Genome Announc. 2015 Jul 2;3(4). pii: e00758-15. doi: 10.1128/genomeA.00758-15.

15.

Resistance to pyrazinamide in Russian Mycobacterium tuberculosis isolates: pncA sequencing versus Bactec MGIT 960.

Maslov DA, Zaĭchikova MV, Chernousova LN, Shur KV, Bekker OB, Smirnova TG, Larionova EE, Andreevskaya SN, Zhang Y, Danilenko VN.

Tuberculosis (Edinb). 2015 Sep;95(5):608-12. doi: 10.1016/j.tube.2015.05.013. Epub 2015 Jun 2.

PMID:
26071666
16.

5-Arylaminouracil Derivatives: New Inhibitors of Mycobacterium tuberculosis.

Matyugina E, Novikov M, Babkov D, Ozerov A, Chernousova L, Andreevskaya S, Smirnova T, Karpenko I, Chizhov A, Murthu P, Lutz S, Kochetkov S, Seley-Radtke KL, Khandazhinskaya AL.

Chem Biol Drug Des. 2015 Dec;86(6):1387-96. doi: 10.1111/cbdd.12603. Epub 2015 Jul 14. Erratum in: Chem Biol Drug Des. 2016 Feb;87(2):312.

PMID:
26061192
17.

Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis.

Cegielski JP, Dalton T, Yagui M, Wattanaamornkiet W, Volchenkov GV, Via LE, Van Der Walt M, Tupasi T, Smith SE, Odendaal R, Leimane V, Kvasnovsky C, Kuznetsova T, Kurbatova E, Kummik T, Kuksa L, Kliiman K, Kiryanova EV, Kim H, Kim CK, Kazennyy BY, Jou R, Huang WL, Ershova J, Erokhin VV, Diem L, Contreras C, Cho SN, Chernousova LN, Chen MP, Caoili JC, Bayona J, Akksilp S; Global Preserving Effective TB Treatment Study (PETTS) Investigators.

Clin Infect Dis. 2014 Oct 15;59(8):1049-63. doi: 10.1093/cid/ciu572. Epub 2014 Jul 23.

18.

[Synthesis and biological properties of α-thymidine 5'-aryl phosphonates].

Ivanov MA, Karpenko IL, Chernousova LN, Andreevskaia SN, Smirnova TG, Aleksandrova LA.

Bioorg Khim. 2013 Nov-Dec;39(6):718-27. Russian.

PMID:
25696933
19.

Inhibition of Mycobacterium tuberculosis strains H37Rv and MDR MS-115 by a new set of C5 modified pyrimidine nucleosides.

Shmalenyuk ER, Chernousova LN, Karpenko IL, Kochetkov SN, Smirnova TG, Andreevskaya SN, Chizhov AO, Efremenkova OV, Alexandrova LA.

Bioorg Med Chem. 2013 Sep 1;21(17):4874-84. doi: 10.1016/j.bmc.2013.07.003. Epub 2013 Jul 11.

PMID:
23891229
20.

Comparative genomic analysis of Mycobacterium tuberculosis drug resistant strains from Russia.

Ilina EN, Shitikov EA, Ikryannikova LN, Alekseev DG, Kamashev DE, Malakhova MV, Parfenova TV, Afanas'ev MV, Ischenko DS, Bazaleev NA, Smirnova TG, Larionova EE, Chernousova LN, Beletsky AV, Mardanov AV, Ravin NV, Skryabin KG, Govorun VM.

PLoS One. 2013;8(2):e56577. doi: 10.1371/journal.pone.0056577. Epub 2013 Feb 20.

21.

Performance of Cepheid ® Xpert MTB/RIF ® and TB-Biochip ® MDR in two regions of Russia with a high prevalence of drug-resistant tuberculosis.

Kurbatova EV, Kaminski DA, Erokhin VV, Volchenkov GV, Andreevskaya SN, Chernousova LN, Demikhova OV, Ershova JV, Kaunetis NV, Kuznetsova TA, Larionova EE, Smirnova TG, Somova TR, Vasilieva IA, Vorobieva AV, Zolkina SS, Cegielski JP.

Eur J Clin Microbiol Infect Dis. 2013 Jun;32(6):735-43. doi: 10.1007/s10096-012-1798-0. Epub 2012 Dec 22.

22.

The synthesis and antituberculosis activity of 5'-nor carbocyclic uracil derivatives.

Matyugina E, Khandazhinskaya A, Chernousova L, Andreevskaya S, Smirnova T, Chizhov A, Karpenko I, Kochetkov S, Alexandrova L.

Bioorg Med Chem. 2012 Nov 15;20(22):6680-6. doi: 10.1016/j.bmc.2012.09.019. Epub 2012 Sep 19.

PMID:
23062712
23.

Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study.

Dalton T, Cegielski P, Akksilp S, Asencios L, Campos Caoili J, Cho SN, Erokhin VV, Ershova J, Gler MT, Kazennyy BY, Kim HJ, Kliiman K, Kurbatova E, Kvasnovsky C, Leimane V, van der Walt M, Via LE, Volchenkov GV, Yagui MA, Kang H; Global PETTS Investigators, Akksilp R, Sitti W, Wattanaamornkiet W, Andreevskaya SN, Chernousova LN, Demikhova OV, Larionova EE, Smirnova TG, Vasilieva IA, Vorobyeva AV, Barry CE 3rd, Cai Y, Shamputa IC, Bayona J, Contreras C, Bonilla C, Jave O, Brand J, Lancaster J, Odendaal R, Chen MP, Diem L, Metchock B, Tan K, Taylor A, Wolfgang M, Cho E, Eum SY, Kwak HK, Lee J, Lee J, Min S, Degtyareva I, Nemtsova ES, Khorosheva T, Kyryanova EV, Egos G, Perez MT, Tupasi T, Hwang SH, Kim CK, Kim SY, Lee HJ, Kuksa L, Norvaisha I, Skenders G, Sture I, Kummik T, Kuznetsova T, Somova T, Levina K, Pariona G, Yale G, Suarez C, Valencia E, Viiklepp P.

Lancet. 2012 Oct 20;380(9851):1406-17. doi: 10.1016/S0140-6736(12)60734-X. Epub 2012 Aug 30. Erratum in: Lancet. 2012 Oct 20;380(9851):1386.

PMID:
22938757
24.

Mass spectrometry based methods for the discrimination and typing of mycobacteria.

Shitikov E, Ilina E, Chernousova L, Borovskaya A, Rukin I, Afanas'ev M, Smirnova T, Vorobyeva A, Larionova E, Andreevskaya S, Kostrzewa M, Govorun V.

Infect Genet Evol. 2012 Jun;12(4):838-45. doi: 10.1016/j.meegid.2011.12.013. Epub 2011 Dec 30.

PMID:
22230718
25.

[Chemotherapy of tuberculosis: problems and perspectives].

Vasil'eva IA, Samoĭlova AG, Ergeshov AE, Bagdasarian TR, Chernousova LN.

Vestn Ross Akad Med Nauk. 2012;(11):9-14. Review. Russian.

PMID:
23457975
26.

Effect of exogenous cardiolipin on the growth and viability of Mycobacterium tuberculosis H37Rv in vitro.

Andreevskaya SN, Smirnova TG, Zhogina YA, Smirnova DI, Mikulovich YL, Sorokoumova GM, Chernousova LN, Selishcheva AA, Shvets VI.

Dokl Biol Sci. 2010 Sep-Oct;434:371-4. doi: 10.1134/S0012496610050212. Epub 2010 Oct 21. No abstract available.

PMID:
20963667
27.

Molecular typing of Mycobacterium tuberculosis circulated in Moscow, Russian Federation.

Afanas'ev MV, Ikryannikova LN, Il'ina EN, Kuz'min AV, Larionova EE, Smirnova TG, Chernousova LN, Govorun VM.

Eur J Clin Microbiol Infect Dis. 2011 Feb;30(2):181-91. doi: 10.1007/s10096-010-1067-z. Epub 2010 Oct 13.

PMID:
20941520
28.

[Regulatory effect of complex of natural cytokines and antimicrobial peptides on murine macrophages infected with multidrug-resistant Mycobacterium tuberculosis].

Koval'chuk LV, Gvozdeva IuV, Chernousova LN, Gankovskaia LV, Smirnova TG, Larionova EE, Sokolova EV, Levchenko VA.

Zh Mikrobiol Epidemiol Immunobiol. 2010 May-Jun;(3):52-5. Russian.

PMID:
20734720
29.

Effects of liposomes of different lipid composition on in vitro growth of Mycobacterium tuberculosis H37Rv.

Sorokoumova GM, Andreevskaya SM, Smirnova TG, Petrova EE, Zhogina YA, Kalashnikova TY, Chernousova LN, Selishcheva AA, Shvets VI.

Bull Exp Biol Med. 2009 Nov;148(5):797-9.

PMID:
20396795
30.

New 5-modified pyrimidine nucleoside inhibitors of mycobacterial growth.

Alexandrova LA, Shmalenyuk ER, Kochetkov SN, Erokhin VV, Smirnova TG, Andreevskaia SN, Chernousova LN.

Acta Naturae. 2010 Apr;2(1):108-11.

31.

[The level of cytokines in the ex vivo infection of murine macrophages with Mycobacterium tuberculosis complex].

Chernousova LN, Smirnova TG, Andreevskaia SN, Afanas'eva EG, Timofeev AV.

Tuberk Biolezni Legkih. 2009;(8):46-8. Russian.

PMID:
19803350
32.

[Detection of mutations in codon 306 of the embB gene for molecular genetic characterization of clinical Mycobacterium tuberculosis strains].

Afanas'ev MV, Borovskaia AD, Il'ina EN, Smirnova TG, Larionova EE, Kuz'min AV, Andreevskaia SN, Chernousova LN, Govorun VM.

Probl Tuberk Bolezn Legk. 2009;(5):48-53. Russian.

PMID:
19565815
33.

[Inhibiting effect of complex of natural cytokines and cationic antimicrobial peptides on the growth of Mycobacterium tuberculosis H37Rv in vitro].

Koval'chuk LV, Gvozdeva IuV, Gankovskaia LV, Chernousova LN, Smirnova TG, Larionova EE.

Zh Mikrobiol Epidemiol Immunobiol. 2008 Nov-Dec;(6):35-9. Russian.

PMID:
19186543
34.

[Biological properties of M. Tuberculosis W cluster strains].

Chernousova LN, Andreevskaia SN, Smirnova TG, Zemskova ZS, Larionova EE.

Probl Tuberk Bolezn Legk. 2008;(10):45-50. Russian.

PMID:
19069194
35.

Detection of mutations in Mycobacterium tuberculosis genome determining resistance to fluoroquinolones by hybridization on biological microchips.

Antonova OV, Gryadunov DA, Lapa SA, Kuz'min AV, Larionova EE, Smirnova TG, Nosova EY, Skotnikova OI, Chernousova LN, Moroz AM, Zasedatelev AS, Mikhailovich VM.

Bull Exp Biol Med. 2008 Jan;145(1):108-13.

PMID:
19024017
36.

Ex vivo production of interferon-gamma, tumor necrosis factor-alpha, and interleukin-6 by mouse macrophages during infection with M. bovis and M. tuberculosis H37Rv.

Chernousova LN, Smirnova TG, Afanasieva EG, Karpov VL, Timofeev AV.

Bull Exp Biol Med. 2007 Nov;144(5):709-12.

PMID:
18683503
37.

[Use of a mini-sequencing test, followed by the MALDI-TOF mass-spectrometric analysis to evaluate rifampicin and izoniazid resistance in Mycobacterium tuberculosis circulating in the Russian Federation].

Afanas'ev MV, Ikriannikova LN, Il'ina EN, Smirnova TG, Larionova EE, Kuz'min AV, Chernousova LN, Kamaev EIu, Skorniakov SN, Kinsht VN, Cherednichenko AG, Govorun VM.

Probl Tuberk Bolezn Legk. 2007;(7):37-42. Russian. No abstract available.

PMID:
17722291
38.

[Impact of M. tuberculosis genotype on survival in mice with experimental tuberculosis].

Andreevskaia SN, Chernousova LN, Smirnova TG, Larionova EE, Kuz'min AV.

Probl Tuberk Bolezn Legk. 2007;(7):45-50. Russian.

PMID:
17718073
39.

[Molecular epidemiology of tuberculosis].

Karachunskiĭ MA, Chernousova LN.

Probl Tuberk Bolezn Legk. 2007;(4):3-7. Review. Russian. No abstract available.

PMID:
17663045
40.

Mass-spectrometry based minisequencing method for the rapid detection of drug resistance in Mycobacterium tuberculosis.

Ikryannikova LN, Afanas'ev MV, Akopian TA, Il'ina EN, Kuz'min AV, Larionova EE, Smirnova TG, Chernousova LN, Govorun VM.

J Microbiol Methods. 2007 Sep;70(3):395-405. Epub 2007 May 31.

PMID:
17602768
41.

Molecular characteristics of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates from the Russian Federation.

Afanas'ev MV, Ikryannikova LN, Il'ina EN, Sidorenko SV, Kuz'min AV, Larionova EE, Smirnova TG, Chernousova LN, Kamaev EY, Skorniakov SN, Kinsht VN, Cherednichenko AG, Govorun VM.

J Antimicrob Chemother. 2007 Jun;59(6):1057-64. Epub 2007 Apr 18.

PMID:
17442757
42.

[Examining the ex vivo growth in the macrophages of Mycobacterium tuberculosis of various genotypic clusters].

Andreevskaia SN, Chernousova LN, Smirnova TG, Larionova EE, Kuz'min AV.

Probl Tuberk Bolezn Legk. 2006;(12):43-8. Russian.

PMID:
17300075
44.

[Preponderance of Mycobacterium tuberculosis strains of the family Beijing and risk factors of their transmission in the Samara Region].

Balabanova IaM, Nikolaevskiĭ VV, Raddi M, Drobnevskiĭ F, Fedorin IM, Erokhin VV, Kuznetsov SI, Zakharova SM, Melent'ev AS, Chernousova LN, Golyshevskaia VI.

Probl Tuberk Bolezn Legk. 2006;(2):31-7. Russian.

PMID:
16610308
45.

[Antimycobacterial activity of a dry birch bark extract on a model of experimental pulmonary tuberculosis].

Demikhova OV, Balakshin VV, Presnova GA, Bocharova IV, Lepekha LN, Chernousova LN, Smirnova TG, Pospelov LE, Chistiakov AN.

Probl Tuberk Bolezn Legk. 2006;(1):55-7. Russian.

PMID:
16512188
46.
47.

[Death of honeybee sting].

Lopatkin ON, Morozov IuE, Kopylov AV, Loktev NA, Chernousova LA, Vodolazskaia EV, Totskaia AI.

Sud Med Ekspert. 2006 Jan-Feb;49(1):36-8. Russian. No abstract available.

PMID:
16509211
48.

Evaluation of hybridisation on oligonucleotide microarrays for analysis of drug-resistant Mycobacterium tuberculosis.

Gryadunov D, Mikhailovich V, Lapa S, Roudinskii N, Donnikov M, Pan'kov S, Markova O, Kuz'min A, Chernousova L, Skotnikova O, Moroz A, Zasedatelev A, Mirzabekov A.

Clin Microbiol Infect. 2005 Jul;11(7):531-9.

49.

[Molecular genotyping of Mycobacterium tuberculosis strains isolated from patients in the Samara region by the restriction DNA fragment length polymorphism].

Zheltkova EA, Chernousova LN, Smirnova TG, Andreevskaia SN, Yates M, Drobniewskiĭ F.

Zh Mikrobiol Epidemiol Immunobiol. 2004 Sep-Oct;(5):39-43. Russian.

PMID:
15554311
50.

[Spoligotyping of mycobacterium tuberculosis isolates obtained from patients in the Samara region].

Zheltkova E, Balabanova Ia, Ruddy M, Weldon L, Malomanova N, Elizarova E, Melent'ev A, Mutovkin E, Zakharova S, Fedorin I, Drobnievskiĭ F, Chernousova L.

Zh Mikrobiol Epidemiol Immunobiol. 2004 Jul-Aug;(4):65-7. Russian.

PMID:
15481926

Supplemental Content

Loading ...
Support Center